據悉世茂股份(600823.SH)擬對旗下5項債券展期四年
據消息指,世茂股份(600823.SH)正尋求將境內五筆在上交所上市的公司債券整體展期四年。知情人士表示,該公司計劃自2024年12月份到2026年12月,每三個月支付2%、6%、10%、10%、12%、15%、15%、15%及15%的本金。
世茂股份旗下的上海世茂股份有限公司旗下共發行五項債券,分別為19世茂G3、20世茂G1、20世茂G2、20世茂G3和20世茂G4。
該公司曾經發布公告指,因近期擬就公司債券兌付安排事項召開債券持有人會議,為保證信息披露公平,維護投資者權益,申請所有存續公司債券將自12月9日開市起停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.